Metformin is a first-line oral hypoglycemic agent for treating Type-2 diabetes, which inhibit gluconeogenesis in livers via strengthening hepatic sensitivity to insulin so as to bring down the levels of insulin and glucose in blood circulation. Here, INS is linked to type 2 diabetes mellitus.